HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by SUAREZ, R. D. Articles by PARILLA, B. V. Search for Related Content PubMed PubMed Citation Articles by SUAREZ, R. D. Articles by PARILLA, B. V.

Indomethacin Tocolysis and Intraventricular Hemorrhage

From the Section of Maternal-Fetal Medicine and the Department of Obstetrics and Gynecology, Northwestern Memorial Hospital and Evanston Hospital, Northwestern University Medical School, Chicago, Illinois.

Address reprint requests to: William A. Grobman, MD, MBA Northwestern Memorial Hospital 333 East Superior Street, Suite 410 Chicago, IL 60611 E-mail: w-grobman{at}northwestern.edu

Objective: To determine the association between indomethacin tocolysis and neonatal intraventricular hemorrhage.

Methods: Fifty-six preterm neonates with intraventricular hemorrhage were matched by gestational age with neonates (n = 224) without this morbidity. Maternal and neonatal charts were reviewed to ascertain the type of tocolytic exposure experienced by the neonate. Other maternal and neonatal demographic and outcome data were also abstracted. Results were analyzed using the Student t test, ² analysis, and multivariable logistic regression. The number of studied subjects provided 80% power to determine if antenatal exposure to indomethacin was twice as likely among infants with intraventricular hemorrhage.

Results: Univariate analysis revealed that there were no significant differences between the study and control groups with respect to maternal age, parity, or betamethasone exposure. Infants with intraventricular hemorrhage were significantly more likely to be born at an earlier gestational age, a lower birth weight, after maternal chorioamnionitis, after vaginal delivery, and after exposure to either indomethacin alone or a combination of indomethacin and magnesium. Additionally, their neonatal course was significantly more likely to be complicated by sepsis and respiratory distress syndrome. In a multivariable logistic model, only gestational age, chorioamnionitis, vaginal delivery, and respiratory distress syndrome continued to be significantly associated with intraventricular hemorrhage. Indomethacin exposure, either as single-agent (adjusted odds ratio 1.3, 95% confidence interval 0.5, 3.3) or combination tocolytic therapy (adjusted odds ratio 2.0, 95% confidence interval 0.8, 4.8), was not significantly associated with intraventricular hemorrhage.

Conclusion: Indomethacin tocolysis is not associated with an increased risk of intraventricular hemorrhage.

This article has been cited by other articles:

				S. M. Loe, L. Sanchez-Ramos, and A. M. Kaunitz Assessing the Neonatal Safety of Indomethacin Tocolysis: A Systematic Review With Meta-Analysis Obstet. Gynecol., July 1, 2005; 106(1): 173 - 179. [Abstract] [Full Text] [PDF]